日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase II study of rucaparib and nivolumab in patients with leiomyosarcoma

rucaparib 和 nivolumab 治疗平滑肌肉瘤患者的 II 期研究

Sujana Movva ,Kenneth Seier ,Martina Bradic ,Karmelina Charalambous ,Evan Rosenbaum ,Ciara M Kelly ,Seth M Cohen ,Martee L Hensley ,Viswatej Avutu ,Lauren B Banks ,Jason E Chan ,Ping Chi ,Sandra D'Angelo ,Mark A Dickson ,Mrinal M Gounder ,Mary L Keohan ,Robert G Maki ,Angela Green ,Vicky Makker ,Maria M Rubinstein ,Sara Saunds ,Jae-Mun Cho ,Robert A Lefkowitz ,Joseph Erinjeri ,Li-Xuan Qin ,Ronak Shah ,Phillip Wong ,William Tap

Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma

治疗引起的衰老有助于 Abemaciclib 对去分化脂肪肉瘤患者的疗效

Caroline E Gleason #, Mark A Dickson #, Mary E Klein Dooley, Cristina R Antonescu, Rodrigo Gularte-Mérida, Marimar Benitez, Juliana I Delgado, Raghu P Kataru, Mark Wei Yi Tan, Martina Bradic, Travis E Adamson, Kenneth Seier, Allison L Richards, Marta Palafox, Eric Chan, Sandra P D'Angelo, Mrinal M G